ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
JANX holding history
Janux Therapeutics, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JANX overviewAll 13F holders of JANXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −10,495−100.0% | Sold out | Holders |
| Q4 2025 | 10,495 | $144.8K | <0.1% | +1,621+18.3% | Added | Holders |
| Q3 2025 | 8,874 | $216.9K | <0.1% | −1,410−13.7% | Reduced | Holders |
| Q2 2025 | 10,284 | $237.6K | <0.1% | +771+8.1% | Added | Holders |
| Q1 2025 | 9,513 | $256.9K | <0.1% | −871−8.4% | Reduced | Holders |
| Q4 2024 | 10,384 | $556.0K | <0.1% | +2,003+23.9% | Added | Holders |
| Q3 2024 | 8,381 | $380.7K | <0.1% | +2,863+51.9% | Added | Holders |
| Q2 2024 | 5,518 | $231.1K | <0.1% | −1,137−17.1% | Reduced | Holders |
| Q1 2024 | 6,655 | $250.6K | <0.1% | +6,655 | New | Holders |